Abaxis completes acquisition of QCR & Trio Diagnostics Abaxis, Inc. , a medical products business manufacturing point-of-care consumables and instruments for the medical, research, and veterinary markets providing and world-wide reference lab services to the veterinary and study markets in the United States, announced today the completion of a stock purchase agreement to obtain 100 percent of QCR & Trio Diagnostics Limited, a United Kingdom based distribution organization Click to see more . On November 17 The transaction closed, 2014. Achim Henkel, Managing Director of Abaxis European countries GmbH, commented, ‘After a long and successful cooperation with QCR & Trio Diagnostics as our distribution partner in britain and Ireland, we have now take direct market responsibility by closing on this acquisition.
Each full year, the Volwiler Society issues Outstanding Analysis awards to the Abbott researchers and teams who’ve made significant contributions with their scientific fields. About the Science Survey Science’s annual survey of Top Companies polls workers in the biotechnology, biopharmaceutical, pharmaceutical, and related sectors to look for the driving characteristics of the greatest employers also to determine the 20 best employers in these industries. Respondents to the web-based study were asked to price companies predicated on 23 features, including financial power, easy adaptation to change, and a research-powered environment. The study was conducted and search positions were determined by an unbiased research firm commissioned by the business enterprise office of the journal.